Header Logo

Thomas Wierzba

Concepts (288)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cholera Vaccines
19
2019
19
5.780
Why?
Typhoid Fever
17
2019
19
5.480
Why?
Cholera
21
2019
21
5.170
Why?
Diarrhea
19
2019
56
4.590
Why?
Escherichia coli Infections
14
2019
37
3.950
Why?
Escherichia coli Vaccines
8
2019
10
3.020
Why?
Dysentery, Bacillary
8
2019
13
2.590
Why?
Enterotoxigenic Escherichia coli
8
2019
15
2.300
Why?
Shigella Vaccines
5
2019
5
2.220
Why?
Child, Preschool
45
2019
1126
2.160
Why?
Vaccination
10
2016
93
2.090
Why?
Infant
41
2019
930
2.060
Why?
Child
45
2019
2040
2.020
Why?
Hepatitis E
4
2018
6
1.990
Why?
Salmonella Infections
9
2018
11
1.960
Why?
Developing Countries
8
2019
38
1.800
Why?
Disease Outbreaks
7
2018
35
1.720
Why?
Adolescent
42
2019
3173
1.710
Why?
Antibodies, Bacterial
6
2019
34
1.580
Why?
Mass Vaccination
5
2016
7
1.540
Why?
Influenza, Human
7
2014
119
1.410
Why?
Humans
88
2019
28802
1.350
Why?
Typhoid-Paratyphoid Vaccines
5
2019
6
1.280
Why?
Models, Theoretical
3
2018
138
1.280
Why?
Shigella
5
2019
7
1.210
Why?
Immunity, Herd
4
2019
5
1.200
Why?
Fever
7
2018
56
1.130
Why?
India
13
2018
61
1.090
Why?
Young Adult
28
2019
2400
1.080
Why?
Administration, Oral
14
2019
178
1.060
Why?
Population Surveillance
8
2014
131
1.000
Why?
Bacterial Vaccines
2
2012
7
0.970
Why?
Paratyphoid Fever
2
2019
3
0.950
Why?
Salmonella
3
2018
3
0.920
Why?
Vibrio cholerae
3
2015
3
0.920
Why?
Female
49
2019
18708
0.900
Why?
Adult
34
2019
8600
0.880
Why?
Viral Vaccines
2
2011
12
0.860
Why?
Salmonella typhi
9
2018
10
0.850
Why?
Escherichia coli
5
2014
79
0.850
Why?
Incidence
12
2018
1140
0.810
Why?
Male
46
2019
18398
0.800
Why?
Vaccines, Conjugate
4
2019
16
0.780
Why?
Sanitation
1
2018
5
0.780
Why?
Hygiene
1
2018
17
0.770
Why?
Rotavirus Infections
4
2019
10
0.760
Why?
Mortality
2
2019
109
0.710
Why?
Enteritis
2
2019
5
0.680
Why?
Encephalitis, Japanese
3
2015
3
0.670
Why?
Immunization, Secondary
2
2016
8
0.670
Why?
Severity of Illness Index
3
2016
898
0.640
Why?
Vaccines, Inactivated
9
2018
36
0.630
Why?
Rural Population
8
2016
332
0.630
Why?
Environmental Monitoring
2
2013
32
0.630
Why?
Reagent Kits, Diagnostic
2
2012
8
0.620
Why?
Water Supply
1
2014
12
0.590
Why?
Enteropathogenic Escherichia coli
1
2014
3
0.590
Why?
Diarrhea, Infantile
1
2014
6
0.590
Why?
Influenza A Virus, H1N1 Subtype
2
2012
48
0.590
Why?
Intestinal Perforation
1
2014
9
0.570
Why?
Anti-Bacterial Agents
8
2016
286
0.540
Why?
Salmonella enterica
4
2016
5
0.540
Why?
Cause of Death
1
2014
226
0.520
Why?
Length of Stay
1
2014
287
0.510
Why?
Egypt
12
2014
16
0.500
Why?
Neisseria meningitidis, Serogroup A
1
2012
1
0.500
Why?
Residence Characteristics
2
2016
162
0.480
Why?
Point-of-Care Systems
1
2012
31
0.480
Why?
Africa South of the Sahara
8
2018
12
0.470
Why?
Clinical Trials as Topic
5
2019
324
0.470
Why?
Infant, Newborn
14
2019
566
0.450
Why?
Feces
6
2019
27
0.440
Why?
Bacteremia
3
2016
43
0.440
Why?
Cambodia
8
2014
8
0.430
Why?
Bacterial Infections
2
2012
40
0.430
Why?
Double-Blind Method
7
2018
533
0.430
Why?
Enzyme-Linked Immunosorbent Assay
5
2018
158
0.420
Why?
Campylobacter Infections
2
2008
6
0.420
Why?
Measles
1
2009
2
0.410
Why?
Immunization
2
2019
26
0.410
Why?
Guillain-Barre Syndrome
1
2008
7
0.400
Why?
Tanzania
9
2015
10
0.390
Why?
Congresses as Topic
2
2019
44
0.380
Why?
Malaria
4
2016
8
0.360
Why?
Urban Population
3
2017
76
0.350
Why?
Ciprofloxacin
3
2016
13
0.340
Why?
Cost of Illness
3
2018
60
0.340
Why?
Family Characteristics
2
2017
35
0.330
Why?
Prevalence
6
2016
962
0.330
Why?
Middle Aged
12
2018
11389
0.310
Why?
Risk Factors
5
2018
3659
0.300
Why?
Cohort Studies
8
2019
1721
0.290
Why?
Antibodies, Viral
2
2016
48
0.290
Why?
Japanese Encephalitis Vaccines
2
2015
2
0.290
Why?
Databases, Factual
2
2016
323
0.290
Why?
Socioeconomic Factors
2
2017
434
0.280
Why?
Bangladesh
6
2019
7
0.280
Why?
Drug Resistance, Bacterial
3
2016
38
0.270
Why?
Drug Resistance, Multiple, Bacterial
2
2016
16
0.270
Why?
Patient Acceptance of Health Care
2
2016
162
0.260
Why?
Immunization Schedule
3
2019
23
0.240
Why?
Nepal
3
2014
9
0.240
Why?
Escherichia coli Proteins
3
2005
26
0.220
Why?
Case-Control Studies
5
2015
913
0.210
Why?
Rotavirus Vaccines
1
2019
6
0.210
Why?
Antigens, Bacterial
1
2019
20
0.210
Why?
Geographic Information Systems
1
2019
16
0.210
Why?
Sensitivity and Specificity
5
2012
533
0.200
Why?
Host-Pathogen Interactions
1
2019
28
0.200
Why?
Growth Disorders
1
2019
3
0.200
Why?
Cross-Sectional Studies
5
2016
1355
0.200
Why?
Pregnant Women
1
2018
6
0.200
Why?
Cost-Benefit Analysis
1
2019
155
0.200
Why?
Hepatitis Antibodies
1
2018
1
0.190
Why?
Jaundice
1
2018
4
0.190
Why?
Macaca mulatta
1
2019
312
0.190
Why?
Gastrointestinal Diseases
1
2018
39
0.180
Why?
Disease Models, Animal
2
2019
1023
0.180
Why?
Seroepidemiologic Studies
2
2014
7
0.180
Why?
Treatment Outcome
7
2015
3125
0.180
Why?
Africa
2
2014
23
0.180
Why?
Hepatitis E virus
2
2014
3
0.180
Why?
Vietnam
2
2014
5
0.180
Why?
Drug Resistance, Multiple
1
2017
8
0.180
Why?
Pregnancy
3
2017
758
0.180
Why?
Washington
1
2016
4
0.180
Why?
Microbial Sensitivity Tests
6
2016
52
0.180
Why?
Pregnancy Complications, Infectious
2
2014
28
0.180
Why?
Milk, Human
1
2017
15
0.180
Why?
Fatty Acids, Omega-6
1
2017
31
0.170
Why?
Geography
2
2014
35
0.170
Why?
Education
1
2016
32
0.170
Why?
Influenza A Virus, H9N2 Subtype
2
2014
3
0.170
Why?
Fatty Acids, Omega-3
1
2017
55
0.170
Why?
Endemic Diseases
1
2016
4
0.170
Why?
World Health Organization
2
2014
16
0.170
Why?
Indonesia
1
2016
1
0.170
Why?
Nigeria
1
2016
1
0.170
Why?
Uganda
1
2016
5
0.170
Why?
Enterotoxins
3
2005
6
0.170
Why?
Bacterial Toxins
3
2005
17
0.160
Why?
Aged, 80 and over
5
2016
3877
0.160
Why?
Immunity, Mucosal
1
2016
6
0.160
Why?
Poliovirus
1
2016
3
0.160
Why?
Antibody-Producing Cells
1
2016
3
0.160
Why?
Database Management Systems
1
2016
12
0.160
Why?
Hospitalization
2
2016
364
0.160
Why?
Public Health
2
2014
72
0.160
Why?
Immunoglobulin A
4
2019
8
0.160
Why?
Salmonella paratyphi A
2
2013
2
0.160
Why?
B-Lymphocytes
1
2016
69
0.160
Why?
Haemophilus Vaccines
1
2015
1
0.150
Why?
Bacterial Capsules
1
2015
6
0.150
Why?
Haemophilus Infections
1
2015
5
0.150
Why?
Research Design
2
2015
280
0.150
Why?
Immunoglobulin G
4
2019
101
0.150
Why?
Health Expenditures
1
2015
57
0.150
Why?
Mice
2
2019
2315
0.150
Why?
Aged
6
2016
9938
0.150
Why?
Longitudinal Studies
2
2016
744
0.150
Why?
Bacteriological Techniques
1
2014
16
0.150
Why?
Genotype
2
2014
837
0.140
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2011
250
0.140
Why?
Phenotype
2
2014
656
0.140
Why?
Salmonella Vaccines
1
2013
1
0.140
Why?
Bayes Theorem
1
2014
64
0.140
Why?
Internationality
1
2013
21
0.140
Why?
Population Density
1
2013
6
0.140
Why?
Educational Status
1
2014
171
0.130
Why?
Animals
5
2019
7488
0.130
Why?
Randomized Controlled Trials as Topic
1
2015
447
0.130
Why?
Republic of Korea
1
2012
6
0.130
Why?
Models, Statistical
1
2013
160
0.130
Why?
Computers, Handheld
1
2012
7
0.120
Why?
Niger
1
2012
1
0.120
Why?
Dengue
1
2012
4
0.120
Why?
Delivery of Health Care
1
2014
128
0.120
Why?
Community-Acquired Infections
1
2012
31
0.120
Why?
Influenza A Virus, H3N2 Subtype
1
2011
22
0.120
Why?
Reproducibility of Results
4
2016
717
0.120
Why?
Sex Factors
1
2014
692
0.120
Why?
Data Collection
1
2012
171
0.120
Why?
Vibrio cholerae O1
3
2015
3
0.120
Why?
Rotavirus
1
2010
2
0.110
Why?
Orthomyxoviridae
1
2010
14
0.110
Why?
Health Services Accessibility
1
2012
233
0.110
Why?
Health Knowledge, Attitudes, Practice
1
2014
336
0.110
Why?
Fluoroquinolones
1
2009
10
0.110
Why?
Asia
3
2013
18
0.100
Why?
Gangliosides
1
2008
5
0.100
Why?
Indian Ocean Islands
3
2013
3
0.100
Why?
Cluster Analysis
3
2013
129
0.100
Why?
Prospective Studies
4
2017
2005
0.090
Why?
Azithromycin
2
2004
12
0.090
Why?
Retrospective Studies
3
2014
2913
0.090
Why?
Hospitals
3
2012
69
0.090
Why?
Survival Rate
1
2009
830
0.080
Why?
Vaccines, Subunit
2
2016
3
0.080
Why?
Ghana
2
2016
20
0.080
Why?
Cryptosporidiosis
1
2005
2
0.080
Why?
Cryptosporidium parvum
1
2005
2
0.080
Why?
Seasons
1
2006
101
0.080
Why?
Tuberculosis, Meningeal
1
2005
1
0.080
Why?
Tuberculoma, Intracranial
1
2005
1
0.080
Why?
Granuloma
1
2005
13
0.080
Why?
Interleukin-10
1
2005
26
0.080
Why?
Interferon-gamma
1
2005
51
0.080
Why?
Placebos
2
2015
65
0.070
Why?
Campylobacter coli
1
2003
2
0.070
Why?
Campylobacter jejuni
1
2003
3
0.070
Why?
Biomedical Research
2
2016
164
0.070
Why?
Probability
3
2012
159
0.070
Why?
Cholera Toxin
1
2002
5
0.060
Why?
Age Factors
2
2016
1179
0.060
Why?
Proportional Hazards Models
2
2015
763
0.060
Why?
Serotyping
2
2016
25
0.060
Why?
Adjuvants, Immunologic
1
2002
52
0.060
Why?
Bacteria
2
2012
41
0.060
Why?
Prognosis
3
2016
1394
0.060
Why?
Shigella sonnei
1
2019
1
0.050
Why?
Vaccines, Attenuated
1
2019
11
0.050
Why?
Dose-Response Relationship, Immunologic
1
2019
15
0.050
Why?
Quality-Adjusted Life Years
1
2019
24
0.050
Why?
Luminescent Measurements
1
2018
16
0.050
Why?
Electrochemical Techniques
1
2018
21
0.050
Why?
Age Distribution
2
2012
208
0.050
Why?
Vaccines, Combined
1
2017
2
0.050
Why?
Lactation
1
2017
13
0.040
Why?
Guinea-Bissau
1
2016
1
0.040
Why?
Senegal
1
2016
1
0.040
Why?
Molecular Epidemiology
1
2016
25
0.040
Why?
Clinical Audit
1
2016
1
0.040
Why?
Poliovirus Vaccine, Inactivated
1
2016
1
0.040
Why?
Poliomyelitis
1
2016
2
0.040
Why?
Poliovirus Vaccine, Oral
1
2016
3
0.040
Why?
Antibodies, Neutralizing
1
2016
15
0.040
Why?
Weights and Measures
1
2015
3
0.040
Why?
Anthropometry
1
2016
86
0.040
Why?
Ethiopia
1
2015
1
0.040
Why?
Vibrio cholerae O139
1
2015
1
0.040
Why?
Outpatients
1
2015
51
0.040
Why?
Democratic People's Republic of Korea
1
2015
1
0.040
Why?
Inpatients
1
2015
49
0.040
Why?
Fimbriae Proteins
2
2005
5
0.040
Why?
Influenza A Virus, H5N1 Subtype
1
2014
3
0.040
Why?
Analysis of Variance
1
2016
487
0.040
Why?
History, 21st Century
1
2014
49
0.030
Why?
Vulnerable Populations
1
2014
26
0.030
Why?
History, 20th Century
1
2014
74
0.030
Why?
Drug Discovery
1
2013
32
0.030
Why?
Poverty Areas
1
2013
5
0.030
Why?
Agglutination Tests
1
2012
2
0.030
Why?
Technology, Pharmaceutical
1
2012
3
0.030
Why?
Body Mass Index
1
2017
920
0.030
Why?
Immunization Programs
1
2012
15
0.030
Why?
Communication
1
2014
120
0.030
Why?
Hantavirus
1
2012
1
0.030
Why?
Orientia tsutsugamushi
1
2012
1
0.030
Why?
Rickettsia
1
2012
3
0.030
Why?
Health Policy
1
2012
72
0.030
Why?
Medical Records Systems, Computerized
1
2012
25
0.030
Why?
Specimen Handling
1
2012
25
0.030
Why?
Information Storage and Retrieval
1
2012
27
0.030
Why?
Pilot Projects
1
2014
469
0.030
Why?
Risk
1
2013
306
0.030
Why?
Decision Making
1
2014
183
0.030
Why?
Acute Disease
1
2012
237
0.030
Why?
Feasibility Studies
1
2012
261
0.030
Why?
Models, Biological
1
2013
372
0.030
Why?
Pharyngitis
1
2010
13
0.030
Why?
Cough
1
2010
17
0.030
Why?
RNA, Viral
1
2010
51
0.030
Why?
Time Factors
1
2015
2076
0.030
Why?
Occupational Exposure
1
2013
287
0.020
Why?
Predictive Value of Tests
1
2010
802
0.020
Why?
Virulence Factors
1
2005
9
0.020
Why?
Virulence
1
2004
18
0.020
Why?
Brain
1
2012
962
0.020
Why?
Sex Distribution
1
2005
199
0.020
Why?
Bacterial Proteins
1
2005
71
0.020
Why?
Erythromycin
1
2003
5
0.020
Why?
Multivariate Analysis
1
2005
700
0.020
Why?
Evidence-Based Medicine
1
2004
193
0.020
Why?
Logistic Models
1
2005
773
0.020
Why?
Pediatrics
1
2003
126
0.020
Why?
Antibody Formation
1
2002
37
0.020
Why?
Dose-Response Relationship, Drug
1
2002
668
0.010
Why?
Risk Assessment
1
2005
1346
0.010
Why?
Wierzba's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (288)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_